Redwood Investments’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-74
Closed -$5K 121
2017
Q2
$5K Hold
74
﹤0.01% 153
2017
Q1
$5K Hold
74
﹤0.01% 166
2016
Q4
$5K Hold
74
﹤0.01% 156
2016
Q3
$5K Hold
74
﹤0.01% 159
2016
Q2
$5K Sell
74
-26
-26% -$1.58K ﹤0.01% 171
2016
Q1
$6K Sell
100
-249,086
-100% -$13.9M ﹤0.01% 170
2015
Q4
$14.8M Buy
249,186
+38,682
+18% +$2.23M 1.58% 28
2015
Q3
$11.5M Buy
210,504
+12,859
+7% +$837K 1.52% 31
2015
Q2
$13.3M Buy
197,645
+33,143
+20% +$2.16M 1.65% 21
2015
Q1
$9.63M Sell
164,502
-42,695
-21% -$2.58M 1.54% 27
2014
Q4
$13.6M Sell
207,197
-87,960
-30% -$5.55M 2.05% 16
2014
Q3
$17M Buy
295,157
+63,252
+27% +$3.51M 2.27% 11
2014
Q2
$13.1M Buy
+231,905
New +$12.2M 1.64% 25

Other funds holding ABBV

Redwood Investments's ABBV Position: Q3 2017 in Review

Redwood Investments sold out of AbbVie (ABBV) in Q3 2017, closing a stake of 74 shares — an estimated $5K sold.

Redwood Investments first reported a position in ABBV in Q2 2014 and held it in 13 quarters. The position peaked at $17M in Q3 2014. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

  • Redwood Investments reported no remaining AbbVie position as of Q3 2017 after selling out during the quarter.
  • Redwood Investments sold 74 AbbVie shares in Q3 2017, an estimated $5K.
  • Redwood Investments first reported a position in AbbVie in Q2 2014 and held it in 13 quarters.
  • Redwood Investments's AbbVie position peaked at $17M in Q3 2014.
  • 1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on Redwood Investments's 13F filing for Q3 2017, filed 14 Nov 2017.